Increased brain penetration of diphenhydramine and memantine in rats with adjuvant-induced arthritis.


Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 08 01 2021
revised: 21 05 2021
accepted: 12 07 2021
pubmed: 20 7 2021
medline: 19 3 2022
entrez: 19 7 2021
Statut: ppublish

Résumé

Brain penetration of cationic drugs is an important determinant of their efficacy and side effects. However, the effects of alterations in the activity of uptake transporters in the brain under inflammatory conditions on the brain penetration of cationic drugs are not fully understood. The aim of this study was to examine changes in brain penetration of cationic drugs, including diphenhydramine (DPHM), memantine (MMT), and cimetidine (CMD), and changes in the expression of uptake transporters such as organic cation transporter (Oct) in brain microvascular endothelial cells (BMECs) under inflammatory conditions. To clarify the effects of inflammation on the brain penetration of DPHM, MMT, and CMD, we performed brain microdialysis studies in a rat model of adjuvant-induced arthritis (AA). Further, differences in transporter mRNA expression levels between BMECs from control and AA rats were evaluated. Brain microdialysis showed that the unbound brain-to-plasma partition coefficient (K

Identifiants

pubmed: 34280372
pii: S0006-8993(21)00438-8
doi: 10.1016/j.brainres.2021.147581
pii:
doi:

Substances chimiques

Antiporters 0
Cimetidine 80061L1WGD
Diphenhydramine 8GTS82S83M
Memantine W8O17SJF3T

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

147581

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Atsushi Kawase (A)

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 5778502, Japan.

Akira Kazaoka (A)

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 5778502, Japan.

Hiroaki Shimada (H)

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 5778502, Japan.

Masahiro Iwaki (M)

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka 5778502, Japan; Pharmaceutical Research and Technology Institute, Kindai University, Osaka 5778502, Japan; Antiaging Center, Kindai University, Osaka 5778502, Japan. Electronic address: iwaki@phar.kindai.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH